XIAFLEX is a Kit in the Human Prescription Drug category. It is labeled and distributed by Endo Pharmaceuticals Inc.. The primary component is .
Product ID | 66887-003_0587711f-e9b2-44d7-8e8d-ae9e6615a835 |
NDC | 66887-003 |
Product Type | Human Prescription Drug |
Proprietary Name | XIAFLEX |
Generic Name | Collagenase Clostridium Histolyticum |
Dosage Form | Kit |
Marketing Start Date | 2010-02-22 |
Marketing Category | BLA / BLA |
Application Number | BLA125338 |
Labeler Name | Endo Pharmaceuticals Inc. |
Active Ingredient Strength | 0 |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2010-02-22 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA125338 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2010-02-22 |
Marketing Category | BLA |
Application Number | BLA125338 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2010-02-22 |
SPL SET ID: | 805cecd0-fd1f-11dd-87af-0800200c9a66 |
Manufacturer | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
66887-003 | XIAFLEX | collagenase clostridium histolyticum |
73611-300 | Qwo | collagenase clostridium histolyticum |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
XIAFLEX 77274256 3886633 Live/Registered |
ENDO GLOBAL VENTURES 2007-09-07 |
XIAFLEX 76665957 3785074 Live/Registered |
ENDO GLOBAL VENTURES 2006-09-13 |